Abstract:
Objectives:this study was performed to evaluate the clinical and radiographic success of Ankaferd blood stopper (ABS) alone or in conjunction with low-level laser therapy (LLLT) as pulpotomy agent in primary teeth and compare it with the formocresol (FC) alone or in conjunction with LLLT.
Materials and Methods: Children aged between 3-9 years were included in the present study following specific inclusion and exclusion criteria. . The involved teeth were equally categorized into four groups according to the type of pulpotomy agent; ABS alone (G I), ABS followed by LLLT (G II), FC (G III), and FC followed by LLLT (G IV). The clinical and radiographic evaluations were performed after 3 months, 6 months, 9 months, and 12 months following specific designed criteria.
Results: The results of this study revealed that the use of ABS has better clinical and radiographic success rates when compared with the FC either alone or in conjunction with low-level laser therapy but without statistically significant. Also, the results showed that the use of LLLT improve the clinical and radiographic success outcomes of both of ABS and FC but without statistically significant.
Conclusion: ABS could be used as successful alternative to FC during pulpotomy treatment. Low-Level Laser Therapy has positive effect on the clinical and radiographic outcomes of the ABS and FC pulpotomy medicaments.
Keywords: Ankaferd Blood Stopper, Formocresol, Low-Level Laser Therapy, Pulpotomy, Primary Teeth